Government S Pre Litigation Conduct Cannot Justify a Court of Claims Fee Award
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Before Dyk, Wallach, and Chen. Appeal from the United States Court of Federal Claims.
Summary: A Court of Claims fee award under 28 U.S.C. § 1498(a), turns on whether the government’s litigation conduct was substantially justified without regard to its pre-litigation conduct.
The Court of Claims found the Navy’s development of certain ship models infringed two FastShip patents. The Court of Claims then awarded $6 million in fees under 28 U.S.C. § 1498(a), finding the government’s conduct, before and during litigation taken “as a whole,” was not substantially justified. The Claims Court faulted the government for failing to award FastShip a contract after it responded to a request for proposals and discussed potential ship designs with government contractors under confidentiality agreements. The Claims Court also found the Navy took an “exceedingly long time” to act on FastShip’s administrative claim that FastShip had initially filed before bringing its Complaint in the Claims Court.
The Federal Circuit vacated the fee award. It held that the relevant conduct for determining whether to award fees does not include “the act of infringement itself, any purported breach of contract, or any other underlying governmental action.” The Claims Court could not consider the Navy’s conduct during the ship procurement process or during the administrative proceeding. The Federal Circuit vacated the fee award and remanded so the Claims Court could consider whether the government’s litigation conduct alone was sufficient to justify the fee award.
Editor: Paul Stewart
Written by: Makoto Tsunozaki, Ph.D. & Mark Kachner
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…